secwatch / observer
8-K filed November 10, 2021, 6:59 PM ET ticker NEO CIK 0001077183
leadership confidence high sentiment neutral materiality 0.55

NeoGenomics appoints David Daly to board, names William Bonello CFO effective Jan 2022

NEOGENOMICS INC

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Kathryn McKenzie

Chief Sustainability and Risk Officer
NEO · NEOGENOMICS INC
Effective
2022-01-01
Filed
November 10, 2021, 6:59 PM ET
Kathryn McKenzie, the Company’s current Chief Financial Officer, was appointed Chief Sustainability and Risk Officer of the Company, also effective January 1, 2022.
Appointed

William Bonello

Chief Financial Officer
NEO · NEOGENOMICS INC
Effective
2022-01-01
Filed
November 10, 2021, 6:59 PM ET
William Bonello, the Company’s current President, Informatics, was appointed Chief Financial Officer of the Company, effective January 1, 2022.
Departed

Douglas VanOort

Director
NEO · NEOGENOMICS INC
Effective
2021-11-10
Filed
November 10, 2021, 6:59 PM ET
Effective today, Douglas VanOort has resigned from the Board.
Appointed

David Daly

Member of the Board
NEO · NEOGENOMICS INC
Effective
2021-11-10
Filed
November 10, 2021, 6:59 PM ET
On November 4, 2021, the Board of Directors (the “Board”) of NeoGenomics, Inc., a Nevada corporation (the “Company”), voted to appoint David Daly to serve as a member of the Board, effective November 10, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathryn McKenzie was appointed as Chief Sustainability and Risk Officer at NEOGENOMICS INC.

Action
appointed
Role
Chief Sustainability and Risk Officer
Exact text from the filing
Kathryn McKenzie, the Company’s current Chief Financial Officer, was appointed Chief Sustainability and Risk Officer of the Company, also effective January 1, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William Bonello was appointed as Chief Financial Officer at NEOGENOMICS INC.

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
William Bonello, the Company’s current President, Informatics, was appointed Chief Financial Officer of the Company, effective January 1, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Douglas VanOort resigned as Director at NEOGENOMICS INC.

Action
resigned
Role
Director
Exact text from the filing
Effective today, Douglas VanOort has resigned from the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

David Daly was appointed as Member of the Board at NEOGENOMICS INC.

Action
appointed
Role
Member of the Board
Exact text from the filing
On November 4, 2021, the Board of Directors (the “Board”) of NeoGenomics, Inc., a Nevada corporation (the “Company”), voted to appoint David Daly to serve as a member of the Board, effective November 10, 2021.
View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR
accession 0001077183-21-000243
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.